Search research articles
Contact Us
Filters
Showing results (391-400 of 505) with videos related to
Page
of 51
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 3, 2025
Single-sample, multi-omic mass spectrometry for investigating mechanisms of drug toxicity
Iqbal Mahmud, Wai-Kin Chan, Karen Yannell, et al.
JAMA
|
November 23, 2006
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT) observational cohort
James N Weinstein, Jon D Lurie, Tor D Tosteson, et al.
Cancer Research
|
June 15, 1987
Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans
R R Eger, D G Covell, J A Carrasquillo, et al.
Spine
|
February 19, 2008
SPORT lumbar intervertebral disk herniation and back pain: does treatment, location, or morphology matter?
Adam M Pearson, Emily A Blood, John W Frymoyer, et al.
JAMA
|
November 23, 2006
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial
James N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
The Journal of Biological Chemistry
|
April 14, 2011
Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus
Andrew D Patterson, Jessica A Bonzo, Fei Li, et al.
Cell Reports
|
August 1, 2019
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A Donehower, Thierry Soussi, Anil Korkut, et al.
Spine
|
May 11, 2010
Surgical versus nonoperative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial
James N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
Spine
|
September 17, 2009
Degenerative spondylolisthesis: does fusion method influence outcome? Four-year results of the spine patient outcomes research trial
William A Abdu, Jon D Lurie, Kevin F Spratt, et al.
Cell Death & Disease
|
July 11, 2021
Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway
Bingbing Dai, Jithesh J Augustine, Ya'an Kang, et al.
Page
of 51
Search research articles
Search
Showing results (391-400 of 505) with videos related to
Sort By:
Page
of 51
Biorxiv : the Preprint Server for Biology
|
March 3, 2025
Single-sample, multi-omic mass spectrometry for investigating mechanisms of drug toxicity
Iqbal Mahmud, Wai-Kin Chan, Karen Yannell, et al.
JAMA
|
November 23, 2006
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT) observational cohort
James N Weinstein, Jon D Lurie, Tor D Tosteson, et al.
Cancer Research
|
June 15, 1987
Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans
R R Eger, D G Covell, J A Carrasquillo, et al.
Spine
|
February 19, 2008
SPORT lumbar intervertebral disk herniation and back pain: does treatment, location, or morphology matter?
Adam M Pearson, Emily A Blood, John W Frymoyer, et al.
JAMA
|
November 23, 2006
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial
James N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
The Journal of Biological Chemistry
|
April 14, 2011
Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus
Andrew D Patterson, Jessica A Bonzo, Fei Li, et al.
Cell Reports
|
August 1, 2019
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A Donehower, Thierry Soussi, Anil Korkut, et al.
Spine
|
May 11, 2010
Surgical versus nonoperative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial
James N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
Spine
|
September 17, 2009
Degenerative spondylolisthesis: does fusion method influence outcome? Four-year results of the spine patient outcomes research trial
William A Abdu, Jon D Lurie, Kevin F Spratt, et al.
Cell Death & Disease
|
July 11, 2021
Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway
Bingbing Dai, Jithesh J Augustine, Ya'an Kang, et al.
Page
of 51